Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Moon-Soo | - |
dc.contributor.author | Yang, Jae-Won | - |
dc.contributor.author | Ko, Young-Hoon | - |
dc.contributor.author | Han, Changsu | - |
dc.contributor.author | Kim, Seung-Hyun | - |
dc.contributor.author | Lee, Min-Soo | - |
dc.contributor.author | Joe, Sook-Haeng | - |
dc.contributor.author | Jung, In-Kwa | - |
dc.date.accessioned | 2021-09-09T08:02:03Z | - |
dc.date.available | 2021-09-09T08:02:03Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2008-06 | - |
dc.identifier.issn | 0009-398X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/123507 | - |
dc.description.abstract | We evaluated plasma levels of DHEA-S and cortisol before and after treating ADHD patients with one of two medications: methylphenidate (n = 12) or bupropion (n = 10). Boys with ADHD (combined type) were evaluated with the Korean ADHD rating scale (K-ARS) and the computerized ADHD diagnostic system (ADS). All assessments were measured at baseline and repeated after 12 weeks. There were significant clinical improvements in both treatment groups as measured by K-ARS and ADS. DHEA-S levels increased from baseline to endpoint, but cortisol levels did not change significantly. This study suggests that both methylphenidate and bupropion increase plasma levels of DHEA-S in boys with ADHD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | DEHYDROEPIANDROSTERONE-SULFATE | - |
dc.subject | DEFICIT/HYPERACTIVITY DISORDER | - |
dc.subject | METABOLISM | - |
dc.subject | RECEPTOR | - |
dc.subject | BRAIN | - |
dc.title | Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Moon-Soo | - |
dc.identifier.doi | 10.1007/s10578-007-0081-6 | - |
dc.identifier.scopusid | 2-s2.0-40449088338 | - |
dc.identifier.wosid | 000253754900007 | - |
dc.identifier.bibliographicCitation | CHILD PSYCHIATRY & HUMAN DEVELOPMENT, v.39, no.2, pp.201 - 209 | - |
dc.relation.isPartOf | CHILD PSYCHIATRY & HUMAN DEVELOPMENT | - |
dc.citation.title | CHILD PSYCHIATRY & HUMAN DEVELOPMENT | - |
dc.citation.volume | 39 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 201 | - |
dc.citation.endPage | 209 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Psychology | - |
dc.relation.journalResearchArea | Pediatrics | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychology, Developmental | - |
dc.relation.journalWebOfScienceCategory | Pediatrics | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | DEHYDROEPIANDROSTERONE-SULFATE | - |
dc.subject.keywordPlus | DEFICIT/HYPERACTIVITY DISORDER | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | BRAIN | - |
dc.subject.keywordAuthor | attention deficit disorder with hyperactivity | - |
dc.subject.keywordAuthor | dehydroepiandrosterone sulfate | - |
dc.subject.keywordAuthor | methylphenidate | - |
dc.subject.keywordAuthor | bupropion | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.